Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the Central Clinical School. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Research area keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2025
Epigenetic programming by histone methyltransferase in the bone marrow hematopoietic stem cells contributes diabetic associated atherosclerosis
Okabe, J., El-Osta, S., Nunes Masi, L., Kaspi, A. D., Murphy, A. J. M. & Cooper, M.
1/08/19 → 31/07/20
Project: Research
Targeting epigenetic pathways that lead to diabetic complications
Cooper, M., El-Osta, S., Jandeleit-Dahm, K. & Quaggin, S.
1/01/18 → 31/12/21
Project: Research
Boosting the immune system to treat diabetic retinopathy
Wilkinson-Berka, J., Mackay, F., Cooper, M., Lim, L. L. P. & Wickremasinghe, S.
1/10/17 → 30/09/20
Project: Research
A novel endogenous inhibitor for the treatment of diabetic nephropathy
Cooper, M. & Kantharidis, P.
1/01/17 → 31/12/19
Project: Research
Research Output 1987 2019
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus
Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., Harrap, S., Mancia, G., Marre, M., Neal, B., Perkovic, V., Poulter, N., Williams, B., Zoungas, S., Chalmers, J., Woodward, M. & on behalf of the ADVANCE Collaborative Group, 1 Jan 2019, In : Hypertension. 73, 1, p. 84-91 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
A promising outlook for diabetic kidney disease
Cooper, M. & Warren, A. M., 1 Feb 2019, In : Nature Reviews Nephrology. 15, 2, p. 68-70 3 p.Research output: Contribution to journal › Article › Other › peer-review
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Ohkuma, T., Jun, M., Chalmers, J., Cooper, M. E., Hamet, P., Harrap, S., Zoungas, S., Perkovic, V., Woodward, M. & on behalf of the ADVANCE Collaborative Group, 7 Jun 2019, In : Clinical Journal of the American Society of Nephrology. 14, 6, p. 862-872 11 p.Research output: Contribution to journal › Article › Research › peer-review
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Warren, A. M., Knudsen, S. T. & Cooper, M. E., 23 May 2019, (Accepted/In press) In : Expert Opinion on Therapeutic Targets. p. 1-7 7 p.Research output: Contribution to journal › Article › Other › peer-review
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
Rosenstock, J., Perkovic, V., Johansen, O. E., Cooper, M. E., Kahn, S. E., Marx, N., Alexander, J. H., Pencina, M., Toto, R. D., Wanner, C., Zinman, B., Woerle, H. J., Baanstra, D., Pfarr, E., Schnaidt, S., Meinicke, T., George, J. T., Von Eynatten, M., McGuire, D. K. & for the CARMELINA Investigators, 1 Jan 2019, In : JAMA. 321, 1, p. 69-79 11 p.Research output: Contribution to journal › Article › Research › peer-review